These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34860357)

  • 1. The Role of Ivabradine in Managing Symptomatic Patients with Chronic Coronary Syndromes: A Clinically Oriented Approach.
    Gowdak LHW
    Cardiol Ther; 2022 Mar; 11(1):163-174. PubMed ID: 34860357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ivabradine in management of stable angina in patients with different clinical profiles.
    Kaski JC; Gloekler S; Ferrari R; Fox K; Lévy BI; Komajda M; Vardas P; Camici PG
    Open Heart; 2018; 5(1):e000725. PubMed ID: 29632676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.
    Perings S; Stöckl G; Kelm M;
    Adv Ther; 2016 Sep; 33(9):1550-64. PubMed ID: 27432382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis.
    Nedoshivin A; Petrova PTS; Karpov Y
    Adv Ther; 2022 Sep; 39(9):4189-4204. PubMed ID: 35842897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study).
    Glezer M; Vasyuk Y; Karpov Y
    Adv Ther; 2018 Mar; 35(3):341-352. PubMed ID: 29508153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A; Tardif JC
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
    Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
    Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
    Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and Impact on Adherence of a New Fixed-Dose Combination of Ivabradine and Metoprolol in a Wide Range of Stable Angina Patients in Real-Life Practice.
    Divchev D; Stöckl G;
    Cardiol Ther; 2019 Dec; 8(2):317-328. PubMed ID: 31410662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivabradine: the hope for a good treatment of ischemic heart disease.
    Riccioni G
    Curr Med Chem; 2013; 20(14):1817-23. PubMed ID: 23394554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Stable Angina with a New Fixed-Dose Combination of Ivabradine and Metoprolol: Effectiveness and Tolerability in Routine Clinical Practice.
    Divchev D; Stöckl G;
    Cardiol Ther; 2017 Dec; 6(2):239-249. PubMed ID: 29116618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A; de Silva R
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine in acute coronary syndromes: Protection beyond heart rate lowering.
    Niccoli G; Borovac JA; Vetrugno V; Camici PG; Crea F
    Int J Cardiol; 2017 Jun; 236():107-112. PubMed ID: 28256323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivabradine: a new frontier in the treatment of stable coronary artery disease and chronic heart failure.
    Gammone MA; Riccioni G; D'Orazio N
    Clin Ter; 2020; 171(5):e449-e453. PubMed ID: 32901791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivabradine: an intelligent drug for the treatment of ischemic heart disease.
    Riccioni G
    Molecules; 2012 Nov; 17(11):13592-604. PubMed ID: 23159921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate modulation in stable coronary artery disease without clinical heart failure: What we have already learned from SIGNIFY?
    Perna GP; Vagnarelli F; Volterrani M; Battistoni I; Rapezzi C
    Contemp Clin Trials Commun; 2016 Dec; 4():58-63. PubMed ID: 29736470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D; Camm JA
    Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
    Sulfi S; Timmis AD
    Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Angina: Where Are We?
    Balla C; Pavasini R; Ferrari R
    Cardiology; 2018; 140(1):52-67. PubMed ID: 29874661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.